Paratek Pharmaceuticals, Inc. (PRTK – Free Report) was a big mover last session, as the company saw its shares rise over 27% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $18.90 –$22.90 in the past one-month time frame, witnessed a sharp increase yesterday.
The move came after news leaked that the company is considering a sale.
The company has seen x negative estimate revisions in the past two months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.
Paratek Pharmaceuticals, Inc. Price and Consensus
Paratek Pharmaceuticals, Inc. Price and Consensus | Paratek Pharmaceuticals, Inc. Quote
Paratek Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
A better-ranked stock in the Biomedical and Genetics industryis Alexion Pharmaceuticals, Inc.(ALXN – Free Report) , which currently carries a Zacks Rank #1 (Strong Buy).
